opium addicted patients. Mental and behavioral disorders due to use of opioids
Conditions
Interventions
Intervention 1: two Intervention groups treated with naltrexone made by researcher in very low dose of 0.125 and 0.250 mg used oral and daily for 10 days. Intervention 2: Control group treated with su
Treatment - Drugs
Placebo
two Intervention groups treated with naltrexone made by researcher in very low dose of 0.125 and 0.250 mg used oral and daily for 10 days
Control group treated with sugar powder made by researcher used oral and daily for 10 days
Sponsors
Vice Chancellor for Research of Mashhad University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Male patients who choose outpatient protocol for detoxification of opioids including opium, heroin, crack and tramadol ;filling the consent Exclusion Criteria: Cancer; Known pain syndrome; Diabetes
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical findings of withdrawal syndrome. Timepoint: 1, 4 and 10 days after the beginning of study. Method of measurement: clinical examination by researcher. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Reza Afshari
Medical Toxicology Research Center of Mashhad University of Medical Sciences
Outcome results
None listed